2025-10-24 - Analysis Report
Okay, here's an analysis of Honeywell International Inc (HON) based on the data provided.

**Report on Honeywell International Inc (HON)**

**Company Overview:**  Honeywell International Inc. is a diversified technology and manufacturing company.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return:**
    *   HON: 14.70%
    *   VOO: 99.09%
*   **Divergence:**
    *   Current: -85.4
    *   Range: Max 14.0, Min -88.5
    *   Relative Divergence: 3.0

    *HON has significantly underperformed the S&P 500 over the observed period. The relative divergence of 3.0 suggests HON's performance is near the lower end of its historical range compared to VOO.*

*Alpha, Beta Analysis Table:*

| Year       | CAGR  | MDD   | Alpha | Beta | Cap(B) |
|------------|-------|-------|-------|------|--------|
| 2015-2017  | 33.0% | 67.0% | 4.0%  | 0.2  | 98.5   |
| 2016-2018  | 16.0% | 70.8% | 1.0%  | 0.3  | 88.5   |
| 2017-2019  | 29.0% | 71.0% | 7.0%  | 1.2  | 118.6  |
| 2018-2020  | 6.0%  | 79.5% | -17.0% | 1.2  | 142.5  |
| 2019-2021  | 19.0% | 79.5% | -28.0% | 1.3  | 139.7  |
| 2020-2022  | 9.0%  | 79.5% | 10.0% | 1.4  | 143.6  |
| 2021-2023  | -8.0% | 78.0% | -10.0% | 1.2  | 140.5  |
| 2022-2024  | -2.0% | 79.7% | -22.0% | 1.2  | 151.4  |
| 2023-2025  | -16.0% | 79.7% | -80.0% | 2.0  | 140.1  |

*   **CAGR:** Varies significantly year to year, showing volatile growth patterns.
*   **MDD:** High Maximum Drawdown indicates high risk in all periods.
*   **Alpha:** Mostly negative alpha indicates underperformance relative to the benchmark, particularly in recent years.
*   **Beta:** Beta values consistently above 1 suggest higher volatility than the market, especially in 2023-2025.
*   **Cap:** Market capitalization has generally increased but slightly dropped recently.

**2. Recent Stock Price Movements**

*   **Current Price:** 209.08
*   **Last Market Data:** Price 220.67, Previous Close 206.61, Change 6.81
*   **Moving Averages:**
    *   5-day: 204.75
    *   20-day: 206.96
    *   60-day: 213.30

    *The stock price closed at 209.08, with the last market data showing a significant price increase to 220.67 compared to the previous close of 206.61, indicating a strong positive change of 6.81. The 5-day and 20-day moving averages are below the 60-day moving average, suggesting potential short-term upward momentum. The recent price surge to 220.67 compared to the closing price of 209.08 might be due to market fluctuations or specific company news.*

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 48.36 (Neutral)
*   **PPO:** 0.21 (Neutral)
*   **Hybrid Signal:** "cash_0%_Buy 100% of cash (5 shares - Very Safe - MRI:0.90)"
*   **Recent (20-day) Relative Divergence Change:** -2.2 (Short-term decrease)
*   **Expected Return:** -920.1% (Significant underperformance vs. S&P 500 in the long term)

    *The MRI suggests high investment recommendation, yet the dramatically negative expected return indicates significant risk. The Hybrid Signal suggests a fully invested position based on the MRI, but this contradicts the negative expected return. The negative change in relative divergence indicates recent underperformance.*

**4. Recent News & Significant Events**

*   **Net Profit Margin Falls:** Highlights potential challenges in maintaining profitability.
*   **Aerospace Boom Ignites Honeywell Rally:** Positive news, but also mentions a potential breakup.
*   **Nasdaq Snaps 2-Day Fall:** General market news.
*   **US Equity Indexes Advance:** General market news.
*   **Honeywell Stock Jumps on Earnings. Now Comes the Breakup:** Positive earnings, but uncertainty due to a potential breakup.

    *The news headlines suggest mixed signals. While the aerospace boom and positive earnings are encouraging, the potential breakup and falling profit margins introduce uncertainty. The stock jump on earnings reflects positive short-term sentiment, but the breakup could reshape the company.*

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean 1.96)
*   **Target Price:**
    *   Average: 249.40
    *   High: 290.00
    *   Low: 210.00

    *Analysts are generally optimistic, with a "Buy" consensus and a significant upside potential based on the average target price. However, the range between the high and low target prices indicates some uncertainty.*

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2025-10-23 | 2.87 | 10.41 B$    |
| 2025-07-24 | 2.46 | 10.35 B$    |
| 2025-04-29 | 2.24 | 9.82 B$     |
| 2024-10-24 | 2.17 | 9.73 B$     |
| 2025-10-23 | 2.17 | 9.73 B$     |

*EPS shows a positive trend, with a recent increase to 2.87. Revenue also shows growth, reaching 10.41 B$ in the latest quarter. The repeated 2025-10-23 entry with different values suggests a potential data error.*

**6. Financial Information**

Revenue and Profitability:

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-06-30 | $10.35B   | 38.86%        |
| 2025-03-31 | $9.82B    | 38.54%        |
| 2024-12-31 | $10.09B   | 36.38%        |
| 2024-09-30 | $9.73B    | 38.54%        |
| 2024-06-30 | $9.58B    | 38.85%        |

Capital and Profitability:

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-06-30 | $16.09B   | 9.75%   |
| 2025-03-31 | $17.46B   | 8.30%   |
| 2024-12-31 | $18.62B   | 6.90%   |
| 2024-09-30 | $17.41B   | 8.12%   |
| 2024-06-30 | $16.95B   | 9.11%   |

*   **Revenue:** Generally increasing over the past few quarters.
*   **Profit Margin:** Relatively stable, fluctuating around 38%.
*   **Equity:** Decreasing, from $18.62B to $16.09B.
*   **ROE:** Fluctuating, with the highest in the latest quarter (9.75%).

*The data indicates positive revenue and profit margin trends, but decreasing equity might be a concern. The fluctuating ROE suggests varying efficiency in generating profits from equity.*

**7. Overall Analysis**

Honeywell (HON) presents a mixed picture:

*   **Underperformance:** Significant underperformance compared to the S&P 500, as indicated by cumulative returns and negative alpha.
*   **Recent Positive Momentum:** Recent stock price jump and positive earnings reports.
*   **Technical Indicators:** Neutral RSI and PPO. Hybrid signal suggests a buying opportunity based on a high MRI, but this contradicts the highly negative expected return.
*   **News & Events:** Positive short-term reactions to earnings are tempered by concerns about falling profit margins and a potential breakup.
*   **Analyst Opinions:** Analysts are generally positive ("Buy" consensus) with a substantial average target price.
*   **Financial Data:** Improving revenue and profit margins but declining equity.

**Conclusion:**

HON appears to be at a critical juncture. Recent earnings and positive analyst ratings offer potential for short-term gains. However, the significant underperformance relative to the S&P 500, the potential company breakup, and the contradictory signals from technical indicators (high MRI but very negative expected return) suggest considerable risk. Investors should carefully weigh the potential short-term gains against the longer-term uncertainties before making investment decisions. The discrepancy between the MRI and expected return warrants further investigation.
